Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px

News > All

Total search results: 5334 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 43 44 45 ... 52 53 54  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich. 2017-11-16
Goodwin Procter LLP. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock". 2017-11-16
High-Tech Gründerfonds Management GmbH. (11/16/17). "Press Release: EWE Invests in High-Tech Gründerfonds III". 2017-11-16
Molecular Health GmbH. (11/16/17). "Press Release: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction". Cambridge, MA. 2017-11-16
Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. 2017-11-16
Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen. 2017-11-16
bio.logis Genetic Information Management GmbH. (11/16/17). "Press Release: Laboratory Group Laboratoires Réunis Capitalizes Genetic Information Management Software Suite for Complex Laboratory Reports". 2017-11-16
Curetis N.V.. (11/16/17). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months of 2017". Amsterdam & Holzgerlingen. 2017-11-16
Roche. (11/16/17). "Press Release: FDA Approves Roche’s Hemlibra (emicizumab-kxwh) for Haemophilia A with Inhibitors". Basel. 2017-11-16
Boehringer Ingelheim. (11/15/17). "Press Release: Key Sub-analyses of RE-DUAL PCI Showed Large Reductions in the Incidence of Bleeding Complications if Pradaxa (dabigatran etexilate) Dual Therapy Was Used Instead of Warfarin Triple Therapy". Ingelheim. 2017-11-15
Arvinas, LLC. (11/15/17). "Press Release: Arvinas Expands Strategic License Agreement with Genentech". New Haven, CT. 2017-11-15
Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. 2017-11-15
Arsanis, Inc.. (11/15/17). "Press Release: Arsanis Announces Pricing of Initial Public Offering". Waltham, MA & Vienna. 2017-11-15
High-Tech Gründerfonds Management GmbH. (11/14/17). "Press Release: Scipio Bioscience Announces Its Seed Funding". 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: Jardiance Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Peripheral Artery Disease". Ingelheim & Indianapolis, IN. 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: New RE-VERSE AD Analyses Provide Additional Insights on Impact of Praxbind (idarucizumab) in Pradaxa (dabigatran etexilate) Patients with Gastrointestinal Bleeding or Needing Emergency Surgery". Ingelheim 2017-11-14
Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT. 2017-11-14
Qiagen N.V.. (11/14/17). "Press Release: Qiagen’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology". Hilden & Germantown, MD. 2017-11-14
Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs". Zug, Cambridge, MA, Tübingen & Boston, MA. 2017-11-13
Boehringer Ingelheim. (11/13/17). "Press Release: Cyltezo, Adalimumab Biosimilar from Boehringer Ingelheim, Approved in Europe for the Treatment of Multiple Chronic Inflammatory Diseases". Ingelheim. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer". Zug & Cambridge, MA. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic [The information contained in this release is not appropriate for audiences in the USA and Canada]". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Introduces Stericup Quick Release System for Improved Cell Culture Filtration". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Receives FDA Approval for New Gonal-f Prefilled Pen [Not intended for U.S. and UK based media]". Darmstadt. 2017-11-13
Royal Philips. (11/13/17). "Press Release: German Armed Forces to Use Customized Philips Lumify Ultrasound for Its Emergency and Rescue Operations". Amsterdam. 2017-11-13
Qiagen N.V.. (11/13/17). "Press Release: Qiagen Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony". Hilden & Germantown, MD. 2017-11-13
EBD Group. (11/13/17). "Press Release: BIO-Europe 2017 Brings over 4,000 Biotech and Pharma Execs to Berlin and Breaks All Previous Partnering Records". Carlsbad, CA & Berlin. 2017-11-13
GNA Biosolutions GmbH. (11/13/17). "Press Release: GNA Biosolutions Reveals New Ultrafast PCR Platform at Medica". Düsseldorf. 2017-11-13
Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg. 2017-11-12
Boehringer Ingelheim. (11/10/17). "Press Release: Boehringer Ingelheim Presents New Data for Pradaxa and Its Specific Reversal Agent Praxbind at AHA Scientific Sessions 2017". Ingelheim. 2017-11-10
DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. 2017-11-09
Vetter Pharma International GmbH. (11/9/17). "Press Release: Vetter Expands Its Footprint in Asia Pacific Region. Company Establishes Its Presence in South Korea". Songdo & Ravensburg. 2017-11-09
Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. 2017-11-09
Neurimmune AG. (11/9/17). "Press Release: Neurimmune Announces Collaboration with Ono Pharmaceutical in Neurodegenerative Diseases Field". Schlieren. 2017-11-09
AvroBio, Inc.. (11/9/17). "Press Release: AvroBio, Inc. Appoints Ian Clark to Its Board of Directors". Cambridge, MA. 2017-11-09
InflaRx N.V.. (11/8/17). "Press Release: InflaRx Announces Pricing of Initial Public Offering". Jena. 2017-11-08
Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London. 2017-11-08
Definiens AG. (11/8/17). "Press Release: Definiens Broadens Immuno-Oncology Service Offer. Predictive Multi-biomarkers for Accelerated Immuno-oncological Progress". Washington, D.C.. 2017-11-08
Evotec AG. (11/8/17). "Press Release: Evotec AG Announces First Nine-month 2017 Results and Corporate Update". Hamburg. 2017-11-08
CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA. 2017-11-08
Endress+Hauser AG. (11/8/17). "Press Release: Endress+Hauser Acquires Blue Ocean Nova. Intelligent Inline Spectrometers Strengthen the Process Analytical Instrumentation Portfolio". 2017-11-08
G1 Therapeutics, Inc.. (11/8/17). "Press Release: G1 Therapeutics Makes Key Executive Appointments. Barclay Phillips Appointed Chief Financial Officer and Senior Vice President, Corporate Development". Research Triangle Park, NC. 2017-11-08
MorphoSys AG. (11/7/17). "Press Release: MorphoSys Announces Third Quarter 2017 Results". Planegg. 2017-11-07
Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon. 2017-11-07
Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. 2017-11-07
Nouscom AG. (11/6/17). "Press Release: NousCom Raises €42 Million Series B Financing". Basel. 2017-11-06
Boehringer Ingelheim. (11/6/17). "Press Release: Efficacy and Safety Maintained in Patients Who Switched from Humira to Biosimilar Cyltezo". Ingelheim. 2017-11-06
Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon. 2017-11-06
Eurofins Scientific. (11/6/17). "Press Release: Eurofins Successfully Prices EUR 400m New Hybrid Bond". 2017-11-06
Evotec AG. (11/6/17). "Press Release: Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build »NEPLEX«". Hamburg. 2017-11-06
Qiagen N.V.. (11/6/17). "Press Release: Qiagen Reports Results for Third Quarter and First Nine Months of 2017". Venlo. 2017-11-06
Glycotope GmbH. (11/3/17). "Press Release: Celonic Acquires Glycotope’s Biomanufacturing Facility". Basel. 2017-11-03
Boehringer Ingelheim. (11/2/17). "Press Release: Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)". Ingelheim & Cambridge, MA. 2017-11-02
Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg. 2017-11-02
Bruker Corporation. (11/2/17). "Press Release: Bruker Reports Third Quarter 2017 Financial Results". Billerica, MA. 2017-11-02
Servier. (11/2/17). "Press Release: Servier Germany to Co-promote Novartis’ Blockbuster Entresto". 2017-11-02
Merck KGaA. (11/1/17). "Press Release: Merck and Samsung BioLogics to Extend Strategic Alliance". Darmstadt. 2017-11-01
Bruker Corporation. (11/1/17). "Press Release: Bruker Merger of Sweden Subsidiaries". Solna. 2017-11-01
Novartis AG. (10/30/17). "Press Release: Novartis to Present First of its Kind Evidence for Cosentyx on Potential to Maintain Mobility in Patients with AS and PsA". Basel. 2017-10-30
Novartis AG. (10/30/17). "Press Release: Novartis Announces the Planned Acquisition of Advanced Accelerator Applications to Strengthen Oncology Portfolio". Basel. 2017-10-30
CureVac AG. (10/30/17). "Press Release: CureVac Announces Groundbreaking of Industrial-Scale GMP Production Facility for RNA Therapeutics". Tübingen. 2017-10-30
MorphoSys AG. (10/30/17). "Press Release: Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer". Planegg. 2017-10-30
Euronext N.V.. (10/30/17). "Press Release: Theranexus Takes Its First Steps on Euronext Growth". Paris. 2017-10-30
Boehringer Ingelheim. (10/30/17). "Press Release: Boehringer Ingelheim Expands Collaboration with Sarah Cannon Research Institute to Investigate Novel Immuno-oncology Combination Therapy". Ingelheim & Nashville, TN. 2017-10-30
Glycotope GmbH. (10/30/17). "Press Release: Daiichi Sankyo and Glycotope Announce Option Agreement for Antibody Drug Conjugate Strategic Collaboration and Licensing". Tokyo, Basking Ridge, NJ & Berlin. 2017-10-30
Kymera Therapeutics LLC. (10/30/17). "Press Release: Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies". Cambridge, MA. 2017-10-30
Qiagen N.V.. (10/30/17). "Press Release: Qiagen Accelerates Adoption of Molecular Testing for Life Sciences and Molecular Diagnostics Companies with Launch of Custom Solutions Business". Beverly, MA. 2017-10-30
Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. 2017-10-28
Novartis AG. (10/27/17). "Press Release: Sandoz Proposed Biosimilar Pegfilgrastim Accepted by EMA for Regulatory Review". Holzkirchen. 2017-10-27
Clariant. (10/27/17). "Press Release: Clariant and Huntsman Jointly Decided to Abandon Planned Merger of Equals". Muttenz. 2017-10-27
CureVac AG. (10/27/17). "Press Release: CureVac Initiates Phase I Clinical Trial of RNAdjuvant Candidate as Intratumoral Therapy for Solid Tumors". Tübingen & Boston, MA. 2017-10-27
4SC AG. (10/26/17). "Press Release: 4SC Provides Q3 and 9M 2017 Update". Planegg-Martinsried. 2017-10-26
Topas Therapeutics GmbH. (10/26/17). "Press Release: Topas Therapeutics Appoints Rupert Sandbrink, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer". Hamburg. 2017-10-26
Akampion. (10/26/17). "Press Release: Akampion Hosts Expert Panel at BIO-Europe 2017, Co-authors Scientific Article in Human Gene Therapy". 2017-10-26
Evolva Holding S.A.. (10/26/17). "Press Release: Evolva Announces Final Terms of Proposed Capital Increase [Not for release in US, CA, JP or AU or any jurisdiction where unlawful]". 2017-10-26
Evotec AG. (10/26/17). "Press Release: Evotec and Tesaro Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents". Hamburg. 2017-10-26
InSphero AG. (10/26/17). "Press Release: InSphero and Charles River Announce PDX Partnership". Schlieren. 2017-10-26
Novartis AG. (10/25/17). "Press Release: Novartis Confirms Leadership in Multiple Sclerosis (MS) with Scientific Advancements and New Data presented at ECTRIMS". Basel. 2017-10-25
BioMed X GmbH. (10/25/17). "Press Release: BioMed X Announces Biomedical Research Collaboration with Janssen". Heidelberg. 2017-10-25
Thermo Fisher Scientific Inc.. (10/25/17). "Press Release: Thermo Fisher Scientific Reports Third Quarter 2017 Results". Waltham, MA. 2017-10-25
Sygnis AG. (10/24/17). "Press Release: Sygnis AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing". Madrid & Heidelberg. 2017-10-24
Idorsia Ltd.. (10/24/17). "Press Release: Idorsia Announces Financial Results as of 30 September 2017". Allschwil. 2017-10-24
AiCuris Anti-infective Cures GmbH. (10/24/17). "Press Release: AiCuris AIC649 Showed Potential for Functional Cure in Woodchuck Model for Chronic Hepatitis B". Wuppertal. 2017-10-24
Novartis AG. (10/24/17). "Press Release: Novartis Delivered Growth on Top and Bottom Line in All Divisions in Q3". Basel. 2017-10-24
Eurofins Scientific. (10/24/17). "Press Release: With 33% CAGR Annual Value Creation since Its IPO 20 Years Ago (over 296 Times Appreciation) a Study Finds that Eurofins Ranks First in Value Creation of All Stocks ÖListed in Europe since October 24, 1997 2017-10-24
Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Announces Agreement with the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis". South San Francisco, CA. 2017-10-24
Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues". South San Francisco, CA. 2017-10-24
Ionicon Analytik GmbH. (10/24/17). "Press Release: Ionicon Presents the New Charon Aerosol Inlet for PTR-TOFMS". Innsbruck. 2017-10-24
Merck KGaA. (10/24/17). "Press Release: Canadian Patent Office to Grant Merck's Patent Application for CRISPR Technology". Darmstadt. 2017-10-24
Qiagen N.V.. (10/24/17). "Press Release: Qiagen and ICMP Launch Next-generation DNA Testing Solutions for Identifying Missing Persons". The Hague. 2017-10-24
Ascenion GmbH. (10/23/17). "Press Release: Ascenion’s Portfolio Company SurgVision Acquired by Bracco Imaging. Making Cancer Surgery more Precise". Munich. 2017-10-23
Novartis AG. (10/23/17). "Press Release: Novartis Combination Adjuvant Therapy Tafinlar + Mekinist Receives FDA Breakthrough Therapy Designation for Stage III BRAF V600 mutation-positive melanoma patients". Basel. 2017-10-23
Curetis N.V.. (10/23/17). "Press Release: Curetis Initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge". Amsterdam & Holzgerlingen. 2017-10-23
CureVac AG. (10/23/17). "Press Release: Publication in npj Vaccines Demonstrates CureVac’s RNActive Vaccine Is Superior to Licensed Vaccines". Tübingen & Boston, MA. 2017-10-23
MorphoSys AG. (10/23/17). "Press Release: MorphoSys Receives FDA Breakthrough Therapy Designation for Its Antibody MOR208 in Relapsed/Refractory DLBCL". Planegg. 2017-10-23
ADC Therapeutics S.A.. (10/23/17). "Press Release: ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials". Lausanne. 2017-10-23
Thermo Fisher Scientific Inc.. (10/23/17). "Press Release: New Unrivalled Capabilities Take GC-MS to the Next Level of Performance. Enhancements to Thermo Scientific Orbitrap GC-MS Systems". Sunnyvale, CA. 2017-10-23
UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels. 2017-10-20
Aelix Therapeutics S.L.. (10/20/17). "Press Release: Aelix Therapeutics Appoints Dr. Thomas Hecht as Chairman of the Board of Directors". 2017-10-20
next pagenext page 1 2 3 ... 43 44 45 ... 52 53 54  next pagenext page


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top